Black Diamond Therapeutics (BDTX) Return on Assets (2020 - 2026)

Black Diamond Therapeutics' Return on Assets history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
• Return on Assets was 0.0% for Q1 2026 at Black Diamond Therapeutics, down from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.01% in Q2 2023.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2025, when it grew 1 bps.
• Black Diamond Therapeutics' Return on Assets stood at 0.01% in 2022, then rose by 3 bps to 0.01% in 2023, then slipped by 12 bps to 0.01% in 2024, then surged by 106 bps to 0.0% in 2025, then sank by 856 bps to 0.0% in 2026.
• Business Quant data shows BDTX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.